Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1162-1166

  Lin, Manfred Koo Seen ^a   Farewell, Vernon ^a   Vadas, Peter ^a   Bookman, Arthur A M ^a   Keystone, Edward C ^a   Pruzanski, Waldemar ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Activity; Phospholipase A2; Rheumatoid arthritis

Indexed keywords

PHOSPHOLIPASE A2; BIOLOGICAL MARKER; PHOSPHOLIPASE A;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; JOINT EFFUSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; ADOLESCENT; ARTHROPATHY; BLOOD; ENZYME ACTIVATION; ENZYMOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SECRETION; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; ENZYME ACTIVATION; FEMALE; HUMANS; JOINT DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHOLIPASES A; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SYNOVIAL FLUID;

EID: 0029662071     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Harris ED Jr: Etiology and pathogenesis of rheumatoid arthritis. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of Rheumatology, 4th ed. Philadelphia: WB Saunders, 1993:833-73.
2. Evans SW, Whicher JT: An Overview of the Inflammatory Response. London: Kluwer Academic Publishers, 1992:1-15.
3. Bresnihan B: The synovial lining cells in chronic arthritis. Br J Rheumatol / 992/31:433-6.
4. Cush JJ, Lipsky PE: Cellular basis for rheumatoid inflammation. Clin Orthop Rel Res 1991:265:9-21.
5. Baum J, Ziff M: Laboratory findings in rheumatoid arthritis. In: McCarty DJ, ed. Arthritis and Allied Conditions. A Textbook of Rheumatology, llth ed. Philadelphia: Lea and Febiger, 1989:744-60.
6. Holt I, Cooper RG, Denton J, Meager A, Hopkins SJ: Cytokine inter-relationships and their association with disease activity in arthritis. BrJ Rheumatol 7992;31:725-33.
7. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum /990;33:305-15.
8. Pruzanski W, Vadas P: Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis. J Rheumatol /98,-15:1601-3.
9. Pruzanski W, Vadas P: Phospholipase A2 -a mediator between proximal and distal effectors of inflammation. Immunol Today /99/;12:143-6.
10. Vadas P, Pruzanski W: The role of extracellular phospholipase A2 in inflammation. Adv Inflamm Res 1983;l:5\-9.
11. Pruzanski W, Scott K, Smith G, Rajkovic I, Stefanski E, Vadas P: Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation 1992:16:437-13.
12. Stefanski E, Pruzanski W, Sternby B, Vadas P: Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. JBiochem ;986,-100:1297-303.
13. Vadas P, Stefanski E, Pruzanski W: Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. Life Sciences 79S5;36:579-87.
14. Seilhamer JJ, Pruzanski W, Vadas P, et al: Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem /9S9;264:5335-8.
15. Kramer RM, Johansen B, Hayes G, et al: Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem /989;264:5768-75.
16. Pruzanski W, Vadas P, Kim J, Jacobs H, Stefanski E: Phospholipase A2 activity associated with synovial fluid cells. J Rheumatol /98S;15:791-4.
17. Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler PB: Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science /99/;254:1007-10.
18. Wery JP, Schevitz RW, Clawson DK, et al: Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. Nature /99/;352:79-82.
19. Johnson LK, Frank S, Vadas P, et al: Localization and evolution of human phospholipase A2 genes and two related genetic elements. In: Dennis E, Wong PYK, eds. Phospholipase A2: Role and Function in Inflammation. New York: Plenum Press, 1990:17-34.
20. Pruzanski W, Vadas P, Fornasier V: Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. J Invest Dermatol /9S6,'86:380-3.
21. Cirino G, Cicala C, Sorrentino L, Maiello FM, Browning JL: Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch. J Rheumatol 7994;21:824-9.
22. Edelson J, Vadas P, Villar J, Müllen J, Pruzanski W: Phospholipase A2-induced acute lung injury: Structural and functional changes. Am Rev Respir /99/;143:l 102-9.
23. Vadas P, Pruzanski W, Stefanski E, et al: Phospholipase A2 in acute bacterial peritonitis in man. In: Dennis EA, Hunter T, Berridge M, eds. Cell Activation and Signal Initiation: Receptor and Phospholipase Control oflnositol Phosphate, PAF, and Eicosanoid Production. New York: Alan R. Liss, Inc. 1988:311-6.
24. Vadas P, Pruzanski W, Kirn J, Fornasier V: The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase Aj. Am J Pathol /989;134:807-11.
25. Bomalaski JS, Lawton P, Browning JL: Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol 7997;146:3904-10.
26. Murakami M, Kudo I, Nakamura H, Yokoyama Y, Mori H, Inoue K: Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2. FEBS Lett /990;268:113-6.
27. Vishwanath BS, Fawzy AA, Franson RC: Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation 1988; 12:549-61.
28. Pruzanski W, Keystone EC, Sternby B, Bombardier C, Snow KM, Vadas P: Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol /988;15:1351-5.
29. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum /9S8;31:315-24.
30. Franson R, Dobrow R, Weiss J, Eisbach P, Weglicki W: Isolation and characterization of a phospholipase A2 in an inflammatory exudate. J Lipid Res /978;19:18-23.
31. Smith GM, Ward RL, McGuigan L, Rajkovic A, Scott KF: Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol /992/31:175-8.
32. SAS User Guide, Version 6.07.01. Cary, NC: SAS Institute, 1991.
33. Liang K-Y, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika /986/73:13-22.
34. Vadas P, Browning J, Edelson J, Pruzanski W: Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease stales. J Lipid Médiat 7995/8:1-30.
35. Bomalaski JS, Clark MA: Phospholipase A2 and arthritis. Arthritis Rheum 1993 ;36:190-8.